NASH Fibrosis
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo (NCT03479125) | Conatus Pharmaceuticals Inc. | 2018-02-27 |
Track NASH Fibrosis automatically
Every clearance here is in the API, with alerts when new ones post.